Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SANGAMO THERAPEUTICS, INC | SVP, Head of Development | Common Stock | 75.5K | $28.9K | $0.38 | Feb 25, 2022 | Direct |
SANGAMO THERAPEUTICS, INC | SVP, Head of Development | Stock Option (Right to Buy) | 111K | Feb 25, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | SVP, Head of Development |
SGMO | SANGAMO THERAPEUTICS, INC | Feb 12, 2022 | 1 | -$31.5K | 4 | Feb 24, 2022 | SVP, Head of Development |